IP Library › Granted Patent US 12,300,382
Granted Patent B2
US 12,300,382 · App. 18/605,036 · Granted May 13, 2025

Disinfection tracking network

Inventors: Paul Byrne (Washington, DC); David W Baarman (Fennville, MI); Luke Platz (Austin, TX); Colin J. Moore (Grand Rapids, MI)
Assignee: UV Partners, Inc.
G16H40/20A61L2/24A61L2202/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,300,382
App. No.
18/605,036
Filed
Mar 14, 2024
Granted
May 13, 2025
Kind
B2
Art Unit
2161
USPC
15/3
Abstract

A disinfecting tracking network for creating healthier environments. The system and methods for tracking and utilizing this information to build and maintain healthier environments with a laboratory approach to data inputs. This system is a cloud based system with IOT interface and APIs to enable broad reaching inputs for analysis. This system creates a safer ecosystem and cross statistic sharing of performance parameters.

Claims (35)

1. A mobile infection tracking system, the system comprising:

a plurality of mobile devices each mobile device having:

an interface for reporting infectious disease information about a user of the mobile device, wherein infectious disease information is recorded with chronological information in memory as timestamped infectious disease information;

a position tracking system for tracking position of the mobile device, wherein the position tracking information is recorded with chronological information in memory as timestamped position tracking information;

a communication system for communicating the timestamped infectious disease information and the timestamped position tracking information over a network; and

a server configured to receive the timestamped infectious disease information and the timestamped position tracking information over a network from the plurality of mobile devices, wherein the server is configured to estimate infectious disease exposure associated with a user of one of the plurality of mobile devices based on the timestamped position tracking information of the one of the plurality of mobile devices relative to the timestamped position tracking information of the other of the plurality of mobile devices, and the timestamped disease information of the other of the plurality of mobile devices.

2. The mobile infection tracking system of claim 1 wherein the position tracking system of each of the plurality of mobile devices includes a received signal strength indicator (RSSI) for determining strength of signals received from other mobile devices in proximity, wherein the server is configured to estimate infectious disease exposure associated with a user of one of the plurality of mobile devices based, at least in part, on strength of signals received from other mobile devices and the timestamped disease information associated with the other mobile devices.

3. The mobile infection tracking system of claim 1 wherein the position tracking system of each of the plurality of mobile devices includes a global positioning system, wherein the server receives timestamped position information from the plurality of mobile devices and is configured to determine relative positions of the mobile devices based on the timestamped position information.

4. The mobile infection tracking system of claim 1 wherein:

the position tracking system of each of the plurality of mobile devices includes a received signal strength indicator (RSSI) for determining strength of signals received from other mobile devices in proximity and wherein the strength of signals received from other mobile devices in proximity provide position tracking of the mobile device relative to positions of the other mobile devices; and

the position tracking system of each of the plurality of mobile devices includes a global positioning system, wherein the server receives timestamped GPS information from the plurality of mobile devices and the server is configured to determine relative positions of the mobile devices based on the timestamped GPS information.

5. The mobile infection tracking system of claim 1 wherein the timestamped tracked positions include user travel path information, including location information and time information.

6. The mobile infection tracking system of claim 5 , wherein the mobile infection tracking system is configured to provide disease exposure estimates, wherein the disease exposure estimates are generated by a disease exposure analysis conducted by the server that assesses whether a user associated with the one of the plurality of mobile devices was exposed to an infectious disease due to co-locating with one or more users having an infectious disease associated with the other mobile devices, at or before the co-location.

7. The mobile infection tracking system of claim 5 , wherein the mobile infection tracking system is configured to display graphical and textual information related to probabilities of exposure at particular locations.

8. The mobile infection tracking system of claim 5 , wherein the mobile infection tracking system is configured to display graphical and textual information related to infectious disease transmission probabilities associated with attending certain locations.

9. The mobile infection tracking system of claim 5 , wherein the mobile infection tracking system is configured to display graphical and textual information related to paths of users associated with certain infectious disease information.

10. The mobile infection tracking system of claim 1 , wherein the mobile infection tracking system is configured to trigger an alarm in response to determining a mobile device associated with certain infectious disease information is in proximity.

11. The mobile infection tracking system of claim 1 , wherein each mobile device is configured to collect infectious disease transmission data, wherein the infectious disease transmission data weights the infectious disease transmission probabilities.

12. The mobile infection tracking system of claim 5 , including a graphical user interface configured to display user travel path information overlaid with infectious disease information.

13. The mobile infection tracking system of claim 1 , wherein the interface for reporting infectious disease information includes an interface for at least one self-reporting infectious disease symptoms and an interface for entering an infectious disease diagnosis.

14. The mobile infection tracking system of claim 1 , wherein the server is configured to augment the infectious disease exposure estimate based on one or more pathogen factor sensors, each pathogen factor sensor sensing at least one of an infectious disease transmission mitigating factor and an infectious disease transmission exacerbating factor.

15. The mobile infection tracking system of claim 14 , wherein the one or more pathogen factor sensors includes a fan status sensor and the infectious disease exposure estimate is modified based on the fan status sensor information, wherein the fan status sensor information includes at least one of active fan hours and air flow rate information.

16. A method of tracking infectious disease exposure using mobile devices, the method comprising:

tracking, with each of a plurality of personal mobile devices, timestamped position information of the plurality of mobile devices over time, the timestamped position information being associated with respective users of the plurality of personal mobile devices;

associating, with a device interface, timestamped infectious disease information associated with at least some of the respective users of the plurality of personal mobile devices;

receiving, at an analysis device, both the timestamped position information from the plurality of mobile devices and the timestamped infectious disease information associated with at least some of the respective users of the plurality of personal mobile devices;

estimating, with the analysis device, infectious disease exposure associated with a user of one of the plurality of mobile devices based on the timestamped position information of the one of the plurality of mobile devices relative to the timestamped position information of the other of the plurality of mobile devices and the timestamped infectious disease information associated with at least some of the respective users of the plurality of personal mobile devices.

17. The method of tracking infectious disease exposure using mobile devices of claim 16 , further including:

sensing timestamped infectious disease transmission factors over time; and

augmenting the infectious disease exposure estimating based on the timestamped infectious disease transmission factors.

18. The method of tracking infectious disease exposure using mobile devices of claim 17 , wherein the timestamped disease transmission factors include timestamped cleaning information associated with different locations.

19. The method of tracking infectious disease exposure using mobile devices of claim 16 , further including:

sensing, with pathogen factor sensors, timestamped infectious disease transmission exacerbating factors over time; and

in response to identifying an event of interest with a device interface, augmenting the infectious disease exposure estimating based on the timestamped infectious disease transmission exacerbating factors.

20. The method of tracking infectious disease exposure using mobile devices of claim 18 , wherein the event of interest includes an event of interest time and event of interest location where a discrepancy exists between estimated infectious disease exposure and infectious disease information, and wherein the augmenting includes augmenting the infectious disease exposure estimating based on timestamped HVAC information at the event of interest location leading up to the event of interest time.

Continuity (3)
Continuation 17910537
Provisional Application 62988181 · Mar 11, 2020
Related Publication 20240321438A1 · Sep 26, 2024
References Cited (24)
US 3984726A · Ramler · 1976 [cited by applicant]
US 8875284B1 · Newstadt · 2014 [cited by examiner]
US 10198779B2 · Pittman · 2019 [cited by examiner]
US 20100042394A1 · Khan · 2010 [cited by applicant]
US 20100136586A1 · Caufield et al. · 2010 [cited by applicant]
US 20120199003A1 · Melikov et al. · 2012 [cited by applicant]
US 20130115132A1 · Engimann · 2013 [cited by applicant]
US 20130183749A1 · Aamodt et al. · 2013 [cited by applicant]
US 20140167917A2 · Wallace · 2014 [cited by examiner]
US 20160008499A1 · Sunkara et al. · 2016 [cited by applicant]
US 20160212577A1 · Dor et al. · 2016 [cited by applicant]
US 20160306934A1 · Sperry et al. · 2016 [cited by applicant]
US 20170322682A1 · Humayun et al. · 2017 [cited by applicant]
US 20180000428A1 · Swiston · 2018 [cited by examiner]
US 20180144103A1 · Chae et al. · 2018 [cited by applicant]
US 20180366221A1 · Crehore et al. · 2018 [cited by applicant]
US 20180369438A1 · Grossman et al. · 2018 [cited by applicant]
US 20190318815A1 · Bandurski et al. · 2019 [cited by applicant]
US 20190365165A1 · Cawthon et al. · 2019 [cited by applicant]
US 20200273562A1 · Tolbert · 2020 [cited by applicant]
US 20220001050A1 · Terkelsen · 2022 [cited by applicant]
National Institute of Standards and Technology, U.S. Department of Commerce, “What is exerpimental design?” downloaded at https://www.itl.nist.gov/div898/handbook/pri/section1/pri11.htm on Mar. 5, 2020, pp. 1-3. [cited by applicant]
Osterholm et al., “The Ebola Vaccine Team B: a model for promoting the rapid development of medical countermeasures for emerging infectious disease threats”, Lancet Infectious Diseases, vol. 16, Jan. 2016, pp. e1-e9. [cited by applicant]
International Search Report and the Written Opinion of the International Searching Authority for International Application No. PCT/US2021/021629 mailed Aug. 9, 2021, pp. 1-13. [cited by applicant]